Carol M. Mangione, M.D., M.S.P.H.

Carol M. Mangione, M.D., M.S.P.H.
Carol M. Mangione, M.D., M.S.P.H., is the chief of the Division of General Internal Medicine and Health Services Research and the Barbara A. Levey, MD, and Gerald S. Levey, MD, endowed chair in medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), as well as the Department of Medicine executive vice chair for health equity and health services research. She is also a professor of public health at the UCLA Fielding School of Public Health and director of the UCLA Resource Center for Minority Aging Research/Center for Health Improvement of Minority Elderly, associate director of the UCLA Clinical and Translational Sciences (CTSI), and director of the UCLA CTSI Workforce Development Program. Dr. Mangione is also a practicing primary care physician in the UCLA Faculty Practice Group.

Dr. Mangione’s areas of expertise include diabetes, diabetes prevention, health disparities, aging, public health, health insurance benefit design, and public health policy. She is a member of numerous professional societies and organizations, including the National Academy of Medicine, the American Society of Clinical Investigation, the Society for General Internal Medicine, the American Geriatrics Society, AcademyHealth, the American Diabetes Association, and the American College of Physicians. She is also a member of the Board of Governors for the Pardee RAND Graduate School.

Dr. Mangione was the principal investigator for “The Diabetes Health Plan: A System-Level Intervention to Prevent and Treat Diabetes,” funded by the Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to evaluate the effectiveness of the first disease-specific health plan in the United States. This work focused on studying the influence of benefit design on prevention of diabetes, adherence to medications, and control of cardiovascular risk factors among persons with diabetes. Dr. Mangione is the principal investigator of the “Managing Your Medication for Education and Daily Support” (UCMyRx) program, which embeds clinical pharmacists in primary care practices to enhance communication, educate, and improve medication adherence for patients with poor control of cardiovascular risk factors and for older adults who have polypharmacy and are struggling with adherence to their medications. She is co-principal investigator of a grant from NIDDK, “A Cluster-Randomized Trial of Pharmacist-Coordinated Implementation of the Diabetes Prevention Program,” which evaluates a primary care–based program that uses a shared decisionmaking tool to help patients with prediabetes learn about the condition and make treatment choices that will reduce their chance of developing diabetes. She also is the co-principal investigator on an award from the CDC and NIDDK entitled “A Partnered Evaluation of United Health Care’s Medicaid Plan Innovations for Diabetes Patients,” which is evaluating health plan–level innovations designed to improve the care of patients with chronic conditions in the Medicaid expansion population, and in 2020 was awarded by the CDC and NIDDK a project entitled “A Pragmatic Nationwide Randomized, Controlled Trial of Coordinated Medical, Behavioral, and Social Services to Improve Care and Utilization Among High-Cost, High-Need Insured Patients With Diabetes.”

Dr. Mangione was recognized in 2013 with the UCLA Exceptional Physician Award and in 2005 with the Society of General Internal Medicine Mid-Career Mentorship Award. Dr. Mangione has authored more than 300 peer-reviewed articles and seven book chapters.

Dr. Mangione received her B.S. from the University of Michigan, Ann Arbor. She earned her M.D. at the University of California, San Francisco, and completed her residency at University of California Affiliated Hospitals. Dr. Mangione earned her M.S.P.H. from the Harvard School of Public Health and has completed fellowships at Harvard Medical School.

Dr. Mangione was appointed as vice chair in March 2020. She previously served as a member of the U.S. Preventive Services Task Force from January 2016 through December 2019.